Precision drugging of the MAPK pathway in head and neck cancer
Abstract The mitogen-activating protein kinase (MAPK) pathway is central for cell proliferation, differentiation, and senescence. In human, germline defects of the pathway contribute to developmental and congenital head and neck disorders. Nearly 1/5 of head and neck squamous cell carcinoma (HNSCC)...
Main Authors: | Hoi-Lam Ngan, Chun-Ho Law, Yannie Chung Yan Choi, Jenny Yu-Sum Chan, Vivian Wai Yan Lui |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-03-01
|
Series: | npj Genomic Medicine |
Online Access: | https://doi.org/10.1038/s41525-022-00293-1 |
Similar Items
-
MAPKs activation in head and neck squamous cell carcinomas
by: Daniele Maggioni, et al.
Published: (2011-11-01) -
Precision radiotherapy for head and neck cancer: The role of MRI-Linac
by: Chinnasamy Ragavendran
Published: (2024-06-01) -
MYH9 Facilitates Cell Invasion and Radioresistance in Head and Neck Cancer via Modulation of Cellular ROS Levels by Activating the MAPK-Nrf2-GCLC Pathway
by: Guo-Rung You, et al.
Published: (2022-09-01) -
Editorial: Precision therapy and biomarkers in head and neck squamous cell carcinoma
by: Luis Abel Quiñones, et al.
Published: (2024-07-01) -
Identification of mutations in the PYRIN-containing NLR genes (NLRP) in Head and Neck Squamous Cell Carcinoma.
by: Yu Lei, et al.
Published: (2014-01-01)